Acrivon Therapeutics, Inc. Common Stock
Hedge Funds Holdings

Acrivon Therapeutics, Inc. Common Stock‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 91.37% of the total amount of its stocks outstanding. This makes up a total of 3.76M shares of Acrivon Therapeutics, Inc. Common Stock. Compared to the previous quarter, the number fell by -74.84% or -11.19M shares fewer. As for the holding position changes, 15.79% (3) of current hedge fund investors increased the number of shares held, 15.79% (3) of current holders sold a part of the shares held. 12 hedge funds are new holders of Acrivon Therapeutics, Inc. Common Stock stock in Q1 2023, it is 63.16% of total holders.